Novo Nordisk Pharmaceutical 00169770521 - McKesson Medical-Surgical
Novo Nordisk Insulin Information Guide for Health Care Professionals | novoMEDLINK™
Novo Nordisk A/S: Once-weekly Sogroya® (somapacitan) receives CHMP positive opinion for expanded use in children and adolescents with growth hormone deficiency
These highlights do not include all the information needed to use NORDITROPIN safely and effectively. See full prescribing information for NORDITROPIN. NORDITROPIN ® (somatropin) injection, for subcutaneous useInitial U.S. Approval: 1987